Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. (Q53718715)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. |
scientific article |
Statements
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. (English)
1 reference
1 reference
Axel Le Cesne
1 reference
Isabelle Ray-Coquard
1 reference
Florence Duffaud
1 reference
Emmanuelle Bompas
1 reference
Didier Cupissol
1 reference
Jérome Fayette
1 reference
Antoine Adenis
1 reference
Sylvie Chabaud
1 reference
Cecile Guillemet
1 reference
Catherine Delbaldo
1 reference
Patrice Berthaud
1 reference
David Perol
1 reference
Binh Bui
1 reference
Patrice Viens
1 reference
Maria Rios
1 reference
Pierre Kerbrat
1 reference
1 March 2007
1 reference
25
1 reference
9
1 reference
1107-1113
1 reference
Identifiers
1 reference